Aug 3, 2026 09:25AM

Aug 3, 2026 09:24AM

Oct 6, 2025 07:01AM

Oct 6, 2025 07:00AM

Apr 14, 2025 06:11PM

Jan 22, 2025 04:02PM

Jan 22, 2025 04:01PM Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

Jan 22, 2025 04:01PM

Dec 26, 2024 08:08PM

Sep 26, 2022 05:44PM

May 11, 2022 09:18AM

Feb 2, 2022 09:00PM

Jan 28, 2022 09:00PM

Jan 23, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Revance Therapeutics, Cloopen Group, Exicure, and Sleep Number and Encourages Investors to Contact the

Jan 4, 2022 09:00PM

Aug 2, 2021 09:31AM

May 12, 2021 04:05PM

Mar 11, 2021 10:03AM

Mar 11, 2021 08:45AM

Mar 3, 2021 07:04AM

Mar 3, 2021 07:00AM Exicure Granted Orphan Drug Designation by the U.S. Food and Drug Administration for Cavrotolimod

Jan 11, 2021 07:00AM

May 19, 2020 07:07AM

May 19, 2020 07:00AM

Mar 3, 2020 07:00AM

Dec 19, 2019 09:30AM

Dec 16, 2019 07:00AM

Nov 20, 2019 09:16AM Pre-Open 11/20: (ARAV) (I) (TGT) Higher (PDD) (URBN) (MUX) Lower (more...)

Jul 11, 2019 04:30PM

May 8, 2019 04:30PM

Mar 8, 2019 04:56PM

Nov 6, 2018 07:00AM

Jun 14, 2018 07:00AM

328,151 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All